Login

Tomorrow's Company interviews Roger Parry CBE, Chairman of YouGov plc and Oxford Metrics plc, as well as Peter Taylor. 00:10:00

Share On Facebook Share On Twitter

Imogen Moorhouse is CEO/Exec Dir at Oxford Metrics PLC. 

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Banro: Revitalizing Gold Operations in the Congo with Vast Exploration Potential
00:10:00
Paramount Gold Nevada: Advancing Grassy Mountain Towards First Mine Permitting in Oregon
00:10:00
Navigating Market Waves: Insights from Robert Kelly on Elliott Wave Setups and ETF Strategies | Robert Kelly - Editor, U.S. Intraday Stocks Pro Service, Elliott Wave International
00:10:00
TCW's Strategic Partnerships and Market Outlook: Navigating Opportunities Amid Economic Shifts | Katie Koch, CEO , TCW Group.
00:10:00
Adani Wilmar Reports Robust Q2 Growth with EBDITA Surging 4x and Food & FMCG Boost | Angshu Mallick, CEO , Adani Wilmar Ltd.
00:10:00
BLADE CEO Rob Wiesenthal Speaks at 24th Annual Needham Growth Conference | Rob Wiesenthal, CEO, Blade Air Mobility, Inc.
00:10:00
Understanding the Economic Landscape: Perspectives on Financial Health and Long-Term Challenges | Thasunda Brown Duckett, CEO , TIAA.
00:10:00
Powering Uganda's Future: Sustained Investment in Electricity Infrastructure | Selestino Babungi, CEO , Umeme Ltd.
00:10:00
Women Are Natural Problem Solvers|Susan Lyne,Managing Partner and Co-Founder,BBG Ventures
00:10:00
Sun Peak Metals: Exploration and Development in Northern Ethiopia
00:10:00
Advancing Copper-Gold Development: Serengeti Resources' Path to Pre-Feasibility
00:10:00
Critical Elements Lithium: Rose Project and Exploration Update

© 2017 - Neuhu+